Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation

被引:45
作者
Vitale, C
Chiossone, L
Morreale, G
Lanino, E
Cottalasso, F
Moretti, S
Dini, G
Moretta, L
Mingari, MC
机构
[1] Ist Giannina Gaslini, I-16147 Genoa, Italy
[2] Ist Nazl Ric Canc, I-16132 Genoa, Italy
[3] Univ Genoa, Dipartimento Med Sperimentale, Genoa, Italy
[4] Univ Genoa, Ctr Eccellenza Ric Biomed, Genoa, Italy
[5] Univ Genoa, Dipartimento Oncol Biol & Genet, Genoa, Italy
关键词
NK cell differentiation; activating receptor; 2B4; bone marrow transplantation;
D O I
10.1002/eji.200324668
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Patients undergoing allogeneic bone marrow transplantation offer a unique system to analyze NK cell development in vivo. We analyzed NK cells from 23 such patients to assess the acquisition of activating receptors. Four patients displayed an immature NK cell surface phenotype at engraftment, as their cells were CD16(-)KIR(-) and NKG2D(-) but expressed low levels of NKp46, NKp30, 2B4 and NKG2A. These NK cells had particularly low cytolytic activity against the HLA-class-I melanoma F01 cell line and the 721-221 EBV-infected B cell line. Moreover, cytoxicity was inhibited upon mAb-mediated crosslinking of 2B4. Analysis of NK cells at day 30 after bone marrow transplantation revealed the occurrence of both phenotypic and functional maturation. These data are in agreement with a previous in vitro study showing that immature NK cell precursors express CD16, NKG2D and KIR only at a late stage of differentiation and also express inhibitory 2B4. Our present study allows a better understanding of the NK cell differentiation in vivo.
引用
收藏
页码:455 / 460
页数:6
相关论文
共 31 条
[11]  
MINGARI MC, 1997, EUR J IMMUNOL, V27, P1734
[12]   Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis [J].
Moretta, A ;
Bottino, C ;
Vitale, M ;
Pende, D ;
Cantoni, C ;
Mingari, MC ;
Biassoni, R ;
Moretta, L .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :197-223
[13]   Receptors for HLA class-I molecules in human natural killer cells [J].
Moretta, A ;
Bottino, C ;
Vitale, M ;
Pende, D ;
Biassoni, R ;
Mingari, MC ;
Moretta, L .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :619-648
[14]   X-linked lymphoproliferative disease: A progressive immunodeficiency [J].
Morra, M ;
Howie, D ;
Grande, MS ;
Sayos, J ;
Wang, NH ;
Wu, CB ;
Engel, P ;
Terhorst, C .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :657-682
[15]   Role of interleukin-15 in the development of human CD56(+) natural killer cells from CD34(+) hematopoietic progenitor cells [J].
Mrozek, E ;
Anderson, P ;
Caligiuri, MA .
BLOOD, 1996, 87 (07) :2632-2640
[16]  
Orazi A, 1997, AM J CLIN PATHOL, V107, P419
[17]   X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells [J].
Parolini, S ;
Bottino, C ;
Falco, M ;
Augugliaro, R ;
Giliani, S ;
Franceschini, R ;
Ochs, HD ;
Wolf, H ;
Bonnefoy, JY ;
Biassoni, R ;
Moretta, L ;
Notarangelo, LD ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (03) :337-346
[18]   Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells [J].
Pende, D ;
Parolini, S ;
Pessino, A ;
Sivori, S ;
Augugliaro, R ;
Morelli, L ;
Marcenaro, E ;
Accame, L ;
Malaspina, A ;
Biassoni, R ;
Bottino, C ;
Moretta, L ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (10) :1505-1516
[19]  
ROBERTSON MJ, 1990, BLOOD, V76, P2421
[20]   Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants [J].
Ruggeri, L ;
Capanni, M ;
Urbani, E ;
Perruccio, K ;
Shlomchik, WD ;
Tosti, A ;
Posati, S ;
Rogaia, D ;
Frassoni, F ;
Aversa, F ;
Martelli, MF ;
Velardi, A .
SCIENCE, 2002, 295 (5562) :2097-2100